The Indiana University School of Medicine, the Center for Diabetes and Metabolic Diseases, and the Indiana University Precision Health Initiative (PHI) seek to recruit faculty with an established research program in diabetes and an interest in leveraging genomics to develop personalized approaches for diabetes prediction, prevention, and treatment. The Precision Health Initiative was created with the bold goal of addressing major and large-scale health problems facing humanity through multidisciplinary teams of extraordinary and innovative researchers. Precision Health at IU School of Medicine was selected as the first recipient of funding from Indiana University Grand Challenges Program, which is a $300 million research expansion across the entire University. Precision Health has supported the creation of new facilities, centers, and user platforms, including new gene editing and sequencing cores at the IUSM, and a Good Manufacturing Practice Cell Therapy (GMP) facility to produce cellular therapeutics. The $120 million investment in Precision Health will be leveraged to recruit approximately 40 new, full-time faculty members on the Indiana University campuses in Indianapolis and Bloomington. This investment will be used with other IUSM resources to significant expand the scope of this initiative. Diabetes was named a targeted chronic disease for the PHI, which seeks to leverage state of the art genomics, transcriptomics, and informatics to personalize medical care for the 21st Century. This initiative has seen the investment of an additional $8M to establish core resources, prospective biobanking, and therapeutic interventional studies to stratify risk of type 2 diabetes in high-risk cohorts.
Faculty joining the PHI Diabetes Initiative would be joining a vibrant diabetes research community within the IU School of Medicine. IUSM is the home to the Center for Diabetes and Metabolic Diseases (CDMD), which is one of 16 NIH P30 funded Diabetes Research Centers. The CDMD provides support for research cores, pilot and feasibility grant funding, and a number of enrichment activities, including an Annual Diabetes Symposium and weekly multidisciplinary seminar series. IUSM also provides leadership for several large national and international multisite networks and studies, including Type 1 Diabetes TrialNet, the Network for Pancreatic Organ Donors with Diabetes (nPOD), the Integrated Islet Distribution Program, the Immune Tolerance Network, the T1D Exchange, Restoring Insulin Secretion (RISE) study, the Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE) study, and the Human Islet Research Network.
Maintain and expand a strong, extramurally-funded diabetes research program in basic, translational, and/or clinical applications
Be committed to training the next generation of diabetes researchers
Ample opportunities for research and collaboration, including:
The Center for Medical Genomics at IUSM, a state-of-the-art technology center that provides medical scientists with affordable access to high-quality high-throughput genomics services
Genome Services Facility (GSF) that provides consulting and services for the generation of sequencing libraries and next-generation sequencing
The Brown Center for Immunotherapy at IUSM, established with $30 million gift from Dr. Don Brown
The Center for Diabetes and Metabolic Diseases, an NIH-funded P30 Center with state of the art research cores, Pilot and Feasibility program, and Enrichment program. There are currently over 90 members of the Center with research interests that span basic sciences to community-based interventions.
Indiana University is an Equal Opportunity, Affirmative Action employer committed to building a building a diverse learning environment and on supporting the professional development of ethnic minorities, women, and people with disabilities. All qualified applicants will receive consideration for employment without regard to age, color, disability, ethnicity, sex, gender identity, gender expression, genetic information, marital status, national origin, race, religion, sexual orientation, or veteran status.
MD or PhD, or MD/PhD or equivalent
National reputation in diabetes research with a record of scholarship in the discipline and evidence of excellence
Rising stars who have demonstrated unusual talent and a rapid upward trajectory
Department Contact for Questions:
Senem Guler firstname.lastname@example.org
OAA #: IUSM004552016
Internal Number: 6708
About Indiana University
Founded in 1820, Indiana University is the state’s public university system, comprised of two core campuses—IU-Bloomington and IUPUI—and six regional campuses located throughout the state. Combined, the total student population is more than 114,000 undergraduate, graduate and professional school students. IU is one of the largest employers in the state, with over 20,000 faculty and staff. Indiana University is an equal employment and affirmative action employer and a provider of ADA services. Diversity and inclusion remains a core commitment to IU’s mission to cultivate an educational environment that supports equal access, participation and representation on all of its campuses and that provides educational and career opportunities for all.